A bold new indictment of the racialization of science Decades of data cannot be ignored: African American adults are far more likely to develop Type 2 diabetes than white adults. But has science gone so far in racializing diabetes as to undermine the search for solutions? In a rousing indictment of the idea that notions of biological race should drive scientific inquiry, Sweetness in the Blood provides an ethnographic picture of biotechnology’s framings of Type 2 diabetes risk and race and, importantly, offers a critical examination of the assumptions behind the recruitment of African American and African-descent populations for Type 2 diabetes research. James Doucet-Battle begins with a historical overview of how diabetes has been researched and framed racially over the past century, chronicling one company’s efforts to recruit African Americans to test their new diabetes risk-score algorithm with the aim of increasing the clinical and market value of the firm’s technology. He considers African American reticence about participation in biomedical research and examines race and health disparities in light of advances in genomic sequencing technology. Doucet-Battle concludes by emphasizing that genomic research into sub-Saharan ancestry in fact underlines the importance of analyzing gender before attempting to understand the notion of race. No disease reveals this more than Type 2 diabetes. Sweetness in the Blood challenges the notion that the best approach to understanding, managing, and curing Type 2 diabetes is through the lens of race. It also transforms how we think about sugar, filling a neglected gap between the sugar- and molasses-sweetened past of the enslaved African laborer and the high-fructose corn syrup- and corporate-fed body of the contemporary consumer-laborer.

Through the lens of Type 2 diabetes this dissertation considers race and problems of difference and risk with developments in treatment, genomic science, and the conduct of research and research priorities. Based primarily on fieldwork in New York and California, I interrogate public health notions of outreach with biotechnology and clinical research concepts of biomedical translation as synonymous practices. Institutional relationships and marketing drivers, I argue, reflect relatedness back onto the Type 2 diabetes patient through causal narratives of risk and inevitability. In effect, kinship--genetic, familial, racial, ethnic, and environmental--becomes the driver of both risk and emergent forms of bioliterary discipline. I present a narrative of how diabetic risk became racialized over time and how African Americans became seen as a desirable research population. Arguing against biological race, I present an ethnographic example of how one such African American population, or community, emerged from particular social and political histories. Fieldwork uncovered lingering memories of the Tuskegee Experiment combined with cultural incompetency in both public health and biotechnology sectors. Further, I consider the bioethical challenges of African (American) participation in new genomic research aimed toward reducing health disparities. However, as a racial category, genetics researchers debate the precise genetic location and definition of "Africa" in the human genome. I suggest that the search for a pathological Africa in the human genome may deepen racial stigmatization as well as author new narratives of difference. I submit that social disparity, not biological disparity, presents the ultimate challenge to successful effective clinical translation and public health outreach.

Explains what type 2 diabetes is. Discusses the cycle of type 2 diabetes; type 1 vs. type 2 diabetes; risk factors for type 2 diabetes in American Indians; diagnostic criteria for diabetes mellitus, impaired glucose tolerance, and gestational diabetes; management and complications of type 2 diabetes; staged diabetes management; standards of care for patients with diabetes in the Indian Health Service; cultural considerations; and the importance of a diabetes support system.

Embark on a journey of empowerment and hope with "Diabetes Mellitus Type 2: A Guide to Healthy Life." This heartfelt and informative eBook is a lifeline for those touched by Type 2 diabetes, offering not just a wealth of knowledge but also a source of comfort and understanding. This guide is more than just an eBook; it's a companion for those facing the challenges of Type 2 diabetes, whether you're navigating this new reality yourself, caring for a loved one, or seeking to deepen your understanding of this condition. Table of Content Introduction Chapter 1: Understanding Diabetes Mellitus Type 2 Chapter 2: Clinical Presentation and Diagnosis Chapter 3: Complications of Type 2 Diabetes Chapter 4: Management of Type 2 Diabetes Chapter 5: Preventing Type 2 Diabetes Chapter 6: Living with Type 2 Diabetes Chapter 7: Future Directions in Diabetes Management Conclusion What Awaits You Inside: · Compassionate Understanding: Begin with a heartfelt exploration of Type 2 diabetes. Understand what it means to live with this condition, the emotional journey, and the resilience it takes to manage it every day. · Recognizing the Signs: Learn to identify the symptoms and understand the diagnosis process, empowering you with knowledge and the ability to take proactive steps in your healthcare journey. · Preventing and Managing Complications: Delve into the importance of managing diabetes effectively to prevent serious health issues. This section is filled with hope and practical advice on how to live a full life despite these challenges. · Everyday Management Strategies: Discover real-world strategies to manage Type 2 diabetes. From nutrition and exercise to medication management, this guide is filled with actionable advice to improve your daily life. · Embracing a Healthy Lifestyle: Uncover the secrets to not just living but thriving with Type 2 diabetes. Learn how small changes can make a big impact on your health and well-being. · Inspiring Hope for the Future: Stay informed about the advancements in diabetes research and what the future holds, offering hope in the ongoing journey of diabetes management. "Diabetes Mellitus Type 2: A Guide to Healthy Life" is an invitation to embrace your health journey with courage, knowledge, and optimism. It's an eBook that doesn't just inform but also inspires and supports you at every step of the way in managing Type 2 diabetes. Join us in turning the page towards a healthier, more vibrant life with essential guide in your hands.

Learn to live a full and active life with type 2 diabetes Type 2 diabetes is Australia's fast-growing chronic disease, yet it can be prevented with the right diet and regular exercise. Whether you have already been diagnosed with type 2 diabetes or are pre-diabetic and hoping to avoid full-blown diabetes, this easy-to-understand book teaches you how to maintain a healthy lifestyle and good blood glucose control so that you can prevent long-term complications and live a full and active life. An author team of medical professionals, led by Professor Lesley Campbell and Dr. Alan Rubin, offers essential guidance and critical advice for taking preventative measures to avoid developing type 2 diabetes in the first place. For those who have already been diagnosed, the authors walk you through how to deal with type 2 and clearly explain how it affects your body. Highlights ways to manage the daily impact that type 2 has on your life and prevent long-term complications Devotes an entire chapter to foot care Explains glucose monitoring as well as medications that you should be familiar with Details a healthy eating and exercise plan for getting a handle on your type 2 diabetes Makes suggestions for additional resources so you can learn more about your diabetes With a focus on the specific concerns of type 2 diabetes, Type 2 Diabetes For Dummies is a reliable, locally relevant resource on diabetes management.

The latest guidelines for lasting health from the American Diabetes Association Completely revised and updated, this essential resource for people with diabetes includes new information on the rise of type 2 diabetes in children, metabolic syndrome, and the most recent recommendations for diet and exercise. It also provides up-to-the-minute findings on the new diabetes drugs on the market and updated lab test and clinical practice guidelines from the American Diabetes Association.